Translational Oncogenomics (TO)

Publisher : SAGE

Oncology Cancer Research Genomics

Claim Your Journal Get PRC Visit Website

e-ISSN 1177-2727

Issue Frequency Continuously

Est. Year 2006

Mobile 18008187243

DOI YES

Language English

APC YES

Email joan.garrett@uc.edu

Journal Descriptions

Translational Oncogenomics was an international peer reviewed open access scientific journal dedicated to cancer genomics and translational oncology research. The journal focused on bridging laboratory discoveries and clinical applications in cancer diagnosis, prognosis, prevention, and therapy. It published original research articles, reviews, and clinical studies related to molecular oncology, oncogenes, cancer biomarkers, genomic profiling, targeted therapies, tumor biology, and personalized medicine. The journal emphasized translational approaches that connected genomic discoveries with practical clinical outcomes in oncology. Topics included molecular signaling pathways, genetic mutations in cancer, therapeutic resistance, immunotherapy, epigenetics, and precision oncology. It also encouraged interdisciplinary collaboration among cancer biologists, clinicians, geneticists, and pharmaceutical researchers. Originally published by Libertas Academica in New Zealand and later associated with SAGE Publications, the journal was indexed in databases such as PubMed Central, Scopus, EMBase, and EBSCO. Although publication ceased in 2017, archived content remains accessible through CLOCKSS and other repositories.

Translational Oncogenomics (TO) is :-

International, Peer-Reviewed, Open Access, Refereed, Oncology, Cancer Research, Genomics, Molecular Biology, Medical Genetics, Translational Medicine, Precision Medicine, Cancer Biomarkers, Personalized Medicine, oncogenes, cancer biomarkers, genomic profiling, targeted therapies, tumor biology, personalized medicine, molecular signaling pathways, genetic mutations in cancer, therapeutic resistance, immunotherapy, epigenetics, precision oncology, It also encouraged interdisciplinary collaboration among cancer biologists, clinicians, geneticists, pharmaceutical researchers , Online , Continuously Journal
UGC Approved, ISSN Approved: P-ISSN E-ISSN: 1177-2727, Established: 2006,
Provides Crossref DOI
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE